期刊文献+

荷载Zebularine的聚合物胶束复合体纳米颗粒对体外培养的晶状体上皮细胞增殖和黏附的影响 被引量:1

Effect of Zebularine loaded MePEG-PCL nanoparticles on viability,attachment of in vitro cultured lens epithelial cells
下载PDF
导出
摘要 目的:研究荷载Zebularine(Zeb)的聚合物胶束复合体(MePEG-PCL)纳米颗粒(NPs)对体外培养的晶状体上皮细胞(LECs)活性、黏附性和凋亡的影响。方法:体外培养胎儿晶状体组织HLE B-3永生细胞,分为6个组,分别给予游离Zeb 50μmol/L(ZebF1组)、100μmol/L(ZebF2组)、荷载Zeb的MePEG-PCL NPs 50μmol/L(ZebNP1组)、100μmol/L(ZebNP2组)、MePEG-PCL空载颗粒(NPs组)、空白培养基(C组),分别采用MTT比色法、改良MTT比色法观察细胞活性、黏附性,采用DNA ladder法研究细胞凋亡。结果:MTT比色法显示:游离Zeb和荷载Zeb的MePEG-PCL NPs对细胞活性有抑制作用,均呈时间-剂量依赖性增强(P<0.05),与游离组相比,相同剂量荷载Zeb的MePEG-PCL NPs组在给药12h时细胞活性无差异,而给药24,48,96h后载体组细胞活性降低(P<0.05)。改良MTT比色法显示:所有Zeb给药组细胞黏附率均降低,与游离组相比相同剂量荷载Zeb的MePEG-PCL NPs组黏附率降低(P<0.05)。DNA ladder显示:给药后96h C组、NPs组,ZebF1组未出现DNA碎片表达,ZebF2,ZebNP1,ZebNP2组出现DNA碎片表达,其表达强度依次为ZebNP2>ZebNP1>ZebF2(P<0.05)。结论:荷载Zeb的MePEG-PCL NPs可有效地抑制体外培养的LECs活性、黏附性,造成细胞的凋亡,其效果优于同剂量的游离药物。 AIM: To investigate the effect of zebularine( Zeb)loaded Poly( ethylene glycol)- block- poly( ε-caprolactone) methyl ether( MePEG- PCL) nanoparticles( NPs) on the viability,attachment,and apoptosis of in vitro cultured lens epithelial cells( LECs).METHODS: In vitro cultured infant human lens tissue HLE B- 3 immortalized cells were distributed randomly divided into six groups. Each group was administered with free Zeb 50μ mol /L( ZebF1 group),100μ mol /L( ZebF2group), Zeb- loaded MePEG- PCL NPs 50μ mol /L( ZebNP1 group),Zeb-loaded MePEG-PCL NPs100μmol/L( ZebNP2 group),MePEG- PCL empty NPs( NPs group)or blank medium( group C) respectively. A tetrazolium dye assay( MTT) test and modified MTT test were performed to determine cell viability and cell attachment.DNA ladder was used to detect the cell apoptosis.RESULTS: Determined by MTT colorimetric method:Cell proliferation rate of LECs were suppressed by all Zeb administration groups in a concentration- time dependent manner( P 〈 0. 05). Compared with the free Zeb groups,the viability of LECs were suppressed more effectively by the same dose of Zeb loaded MePEG- PCL NPs after 24,48,96h( P 〈 0. 05). Determined by improved MTT colorimetric method: The attachment of LECs were decreased in all Zeb administration groups,Zeb loaded MePEG- PCL NPs had better effect on suppressing the attachment of LECs than the free Zeb groups with same dose( P 〈 0. 05). The DNA ladder confirmed that after administration of 96 h,group C,NPs group and ZebF1 group showed no DNA fragment, however the DNA fragment were performed in ZebF2, ZebNP1, ZebNP2 groups and displays the trend of ZebNP2 〉 ZebNP1 〉ZebF2( P 〈 0. 05).CONCLUSION: Zeb loaded MePEG-PCL NPs had better effect on suppressing the viability and attachment of in vitro cultured LECs than the free Zeb groups,as well as enhancing the apoptosis.
出处 《国际眼科杂志》 CAS 2015年第1期26-29,共4页 International Eye Science
关键词 ZEBULARINE 聚合物胶束复合体纳米颗粒 晶状体上皮细胞 Zebularine; Poly(ethylene glycol)-block-poly(ε-caprolactone) methyl ether; lens epithelial cells
  • 相关文献

参考文献10

  • 1Awasthi N,Guo S,Wagner BJ.Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol 2009; 127(4):555-562.
  • 2Awasthi N, Wang-Su ST, Wagner BJ.Downregulation of MMP-2 and -9 by proteasome inhibition: a possible mechanism to decrease LEC migration and prevent posterior capsular opacification. Invest Ophthalmol Vis Sci 2008; 49(5):1998-2003.
  • 3Zhou P, Lu Y, Sun XH.Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibiting MeCP2. Mol Vis 2011; 17:2717-2123.
  • 4Zhou P, Lu Y, Sun XH.Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial cells. Mol Vis 2012; 18:22-28.
  • 5Yavuz B, Pehlivan SB, Unlu N.Dendrimeric systems and their applications in ocular drug delivery. Scientific WorldJournal 2013; 2013:732340.
  • 6Guha R, Chowdhury S, Palui H,et al.Doxorubicin-loaded MePEG-PCL nanoparticles for prevention of posterior capsular opacification. Nanomedicine(Lond) 2013; 8(9):1415-1428.
  • 7Cheng JC,Yoo CB, Weisenberger DJ,et al.Preferential response of cancer cells to zebularine. Cancer Cell 2004; 6(2):151-158.
  • 8Urtti A, Salminen L.Minimizing systemic absorption of topically administered ophthalmic drugs.Surv Ophthalmol 1993; 37(6):435-456.
  • 9Gan L, Wang J, Jiang M,et al.Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov Today 2013; 18(5-6):290-297.
  • 10Hosny KM.Ciprofloxacin as ocular liposomal hydrogel. AAPS PharmSciTech 2010; 11(1):241-246.

同被引文献12

  • 1余涵,张向东.有晶状体眼前房型人工晶状体植入术治疗高度近视30例疗效观察[J].新乡医学院学报,2005,22(6):595-596. 被引量:2
  • 2Awasthi N, Guo S, Wagner BJ. Posterior capsular opacification: a problem reduced but not yet eradicated[ J]. Arch Ophthalmol, 2009,12(7) :555-552.
  • 3Kohnen T, Fabian E, Gerl R, Hunold W, Hutz W, Strobel J, et o2. Optic edge design as long-term factor for posterior capsular opacification rates [ J ]. Ophthalmology, 2008,11 ( 5 ) : 1308-1314.
  • 4Konno K, Nagamoto T. Membranous proliferation on the posteri- or surface of an intraocular lens after Nd: YAG laser cupsuloto- my[J]. Jpn J Ophthalmol ,2005 , 49 ( 2 ) :173-175.
  • 5Zhou P, Lu Y, Sun XH. Effects of a novel DNA methyltransferase inhibitor Zebularine on human lens epithelial ceUs [J ]. Mol Vis, 2012,18( 1 ) :22-28.
  • 6Guha R, Chowdhury S, Palui H, Mishra A, Basak S, Mandal TK, et al. Doxorubicin-loaded MePEG-PCL nanoparticles for preven- tion of posterior capsular opacification [ J] Nanomedicine (Lond) ,2013,3 ( l 1 ) :l-16.
  • 7Nibourg LM, Gelens E, Kuijer R, Hooymans JM,van Kooten TG, Koopmans SA. Prevention of posterior capsular opacification EJ]. Exp Eye Res ,2015,88 (3) :257-259.
  • 8Hu B, Gharaee-Kermani M, Wu Z, Phan SH. Epigenetic regula- tion of myofibroblast differentiation by DNA methylation [ J ]. Am J Pathol,2010,177 ( 1 ) :21-28.
  • 9Yoo CB, Cheng JC ,Jones PA. Zebularine: a new drug for epige- netic therapy [ J ]. Biochem Soc Trans ,2004 ,32 ( 6 ) :910-912.
  • 10Zhou P, Lu Y, Sun XH. Zebularine suppresses TGF-beta-induced lens epithelial cell-myofibroblast transdifferentiation by inhibi- ting MeCP2[J]. Mol V/s,2011,17(2) :2717-2723.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部